Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice

British Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 884-889

  Misaki, M ^a   Ueyama, Y ^a,b   Tsukamoto, G ^a   Matsumura, T ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Chemotherapy; Cyclophosphamide; Recombinant human granulocyte colony stimulating factor; The timing of rhG CSF administration

Indexed keywords

CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE S PHASE; CELL KINETICS; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031912873     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.146     Document Type: Article

References (10)

1. Bruning JL and Kintz BL (1987) Computational Handbook of Statistics 3rd edn. pp. 275-278. Scott, Foresman: London
2. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Grandishar W, Yahanda A, Vincent M, Stewart M and Glapsy J (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325: 164-170
3. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore M, Clarkson B, Oettgen HF, Alton K, Welte K, and Souza LM (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318: 1414-1422
4. Ikebuchi K, Clark SC, Ihle JN, Souza LM and Ogawa M (1988) Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 85: 3445-3449
5. Morstyn G, Campbell L, Leishke G, Layton JE, Mather D, O'Connor M, Green M, Sheridan W, Vincent M, Alton K, Souza L, McGrath K and Fox RM (1989) Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol 17: 1554-1562
6. Okabe T (1989) Application of human granulocyte colony-stimulating factor to cancer chemo- and radio-therapy. Jpn J Inflammation 9: 231-239
7. Okabe M, Asano M, Kuga T, Komatsu Y, Yamasaki M, Yokoo Y, Itoh S, Morimoto M and Oka T (1990) In vitro and in vivo hematopoietic effect of mutant human granulocyte colony-stimulating factor. Blood 75: 1778-1793
8. Sarosy G, Kohn E, Stone DA, Rothenberg M, Jacob J, Adamo DO, Ognibene FP. Cunnion RE and Reed E (1992) Phase I study of Taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer. J Clin Oncol 10: 1165-1170
9. Takaue Y, Kawano Y, Reading CL, Watanabe T, Abe T, Ninomiya T, Shimizu E, Ogura T, Kuroda Y, Yokobayashi A, Nakahata T, Asano S and Ventura G (1990) Effects of human G-CSF, GM-CSF, IL-3, and IL-1α on the growth of purified human peripheral blood progenitors. Blood 76: 330-335
10. Tanaka H, Ishikawa R, Ishikawa M, Matsui S and Asano K (1991) Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats. Cancer Res 51: 3710-3714